Decap Research & Development from McGill University
DECAP Research & Development Inc. is a biotechnology company based in Vancouver, Canada, and Tel Aviv/Jerusalem, Israel. DECAP has created a suite of devices that will prevent needlestick injuries and potentially save lives. DECAP devices reduce needlestick injury risk, improve workflow and ergonomic performance for healthcare, research, and veterinary workers performing injections on patients and animals.